Manganese-Enhanced Magnetic Resonance Imaging: Applications in Cardiomyopathy
Latest Information Update: 21 May 2024
At a glance
- Drugs Mangafodipir (Primary)
- Indications Cardiomyopathies; Dilated cardiomyopathy; Hypertrophic cardiomyopathy
- Focus Pharmacodynamics
Most Recent Events
- 17 May 2024 Status changed from recruiting to completed.
- 06 Aug 2018 New trial record